Literature DB >> 21866394

Increasing the activity of copper(II) complexes against Leishmania through lipophilicity and pro-oxidant ability.

Andressa dos Santos Portas1, Danilo Ciccone Miguel, Jenicer K U Yokoyama-Yasunaka, Silvia Reni Bortolin Uliana, Breno Pannia Espósito.   

Abstract

Copper complexes with fluorinated β-diketones were synthesized and characterized in terms of lipophilicity and peroxide-assisted oxidation of dihydrorhodamine as an indicator of redox activity. The biological activity of the complexes was tested against promastigotes of Leishmania amazonensis. Inhibition of trypanosomatid-specific trypanothione reductase was also tested. It was found that the highly lipophilic and redox-active bis(trifluoroacetylacetonate) derivative had increased toxicity towards promastigotes. These results indicate that it is possible to modulate the activity of metallodrugs based on redox-active metals through the appropriate choice of lipophilic chelators in order to design new antileishmanials. Further work will be necessary to improve selectivity of these compounds against the parasite. © SBIC 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866394     DOI: 10.1007/s00775-011-0834-3

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  42 in total

1.  Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.

Authors:  T J Benson; J H McKie; J Garforth; A Borges; A H Fairlamb; K T Douglas
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

Review 2.  Thermal stress and the disruption of redox-sensitive signalling and transcription factor activation: possible role in radiosensitization.

Authors:  D Gius; D Mattson; C M Bradbury; D K Smart; D R Spitz
Journal:  Int J Hyperthermia       Date:  2004-03       Impact factor: 3.914

Review 3.  Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases.

Authors:  Silke Overbeck; Lothar Rink; Hajo Haase
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-02-05       Impact factor: 4.291

4.  Potantial utility of disulfiram against leishmaniasis.

Authors:  M R Namazi
Journal:  Indian J Med Res       Date:  2008-02       Impact factor: 2.375

5.  Synthesis and characterization of [Au(dppz)2]Cl3. DNA interaction studies and biological activity against Leishmania (L) mexicana.

Authors:  Maribel Navarro; Clara Hernández; Ibis Colmenares; Paola Hernández; Mercedes Fernández; Anibal Sierraalta; Edgar Marchán
Journal:  J Inorg Biochem       Date:  2006-09-07       Impact factor: 4.155

6.  Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen.

Authors:  U Giri; M Iqbal; M Athar
Journal:  Int J Oncol       Date:  1999-04       Impact factor: 5.650

7.  Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani.

Authors:  Susan Wyllie; Mark L Cunningham; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

8.  Molecular basis of antimony treatment in leishmaniasis.

Authors:  Paola Baiocco; Gianni Colotti; Stefano Franceschini; Andrea Ilari
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

9.  Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol.

Authors:  Yun Ge; Jung S Byun; Paola De Luca; Geraldine Gueron; Idalia M Yabe; Sara G Sadiq-Ali; William D Figg; Jesse Quintero; Cynthia M Haggerty; Quentin Q Li; Adriana De Siervi; Kevin Gardner
Journal:  Mol Pharmacol       Date:  2008-06-12       Impact factor: 4.436

10.  Labile plasma iron in iron overload: redox activity and susceptibility to chelation.

Authors:  Breno P Esposito; William Breuer; Pornpan Sirankapracha; Pensri Pootrakul; Chaim Hershko; Z Ioav Cabantchik
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

View more
  1 in total

Review 1.  Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates.

Authors:  Surbhi Jain; Utkarsha Sahu; Awanish Kumar; Prashant Khare
Journal:  Pharmaceutics       Date:  2022-07-30       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.